Rafael F. Sequeira

TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction

Christopher P. Cannon, C. Michael Gibson, Carolyn H. McCabe et al. · Circulation · 1998 · 356 citations · Full text

Medicine, Cardiology, Pharmacology +15

TNK-Tissue Plasminogen Activator in Acute Myocardial Infarction

Christopher P. Cannon, Carolyn H. McCabe, C. Michael Gibson et al. · Circulation · 1997 · 246 citations

Medicine, Cardiology, Pharmacology +9

Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial

Anthony J. Comerota, Richard C. Throm, Timothy D. Henry et al. · Journal of Vascular Surgery · 2002 · 235 citations · Full text

Medicine, Orthopedic Surgery, Surgery +10

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and Furosemide in Patients With Heart Failure and Systolic Dysfunction

James E. Udelson, Martin Bilsker, Paul J. Hauptman et al. · Journal of Cardiac Failure · 2011 · 98 citations

Medicine, Cardiology, Pharmacology +13

Determinants of coronary blood flow after thrombolytic administration

C. Michael Gibson, Sabina A. Murphy, Ian Menown et al. · Journal of the American College of Cardiology · 1999 · 80 citations

Medicine, Cardiology, Pharmacology +13